Weigh Judgment Before Giving Ramucirumab | Ramucirumab is Viable Choice After REACH-2 Results

Weigh Judgment Before Giving Ramucirumab | Ramucirumab is Viable Choice After REACH-2 Results

User Photo
moasc

2 years
105 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Yung Lyou, MD, UC Irvine Health, talks about Weighing Judgment Before Giving Ramucirumab | Ramucirumab is Viable Choice After REACH-2 Results at MOASC 2018
Up Next Autoplay